U.S.
      SECURITIES AND EXCHANGE
      COMMISSION


Washington,
      DC
      20549









FORM
      10-KSB




S
                Annual
                    report pursuant to section 13 or 15(d) of the Securities Exchange
Act
                    of 1934 for the fiscal year ended December 31, 2006,
                    or
 
 
 £
                Transition
                    report pursuant to section 13 or 15(d) of the Securities Exchange
                    act of 1934 for the transition period from
                    to
  Commission
          File No. 000-15243
 
 CARIBBEAN
          AMERICAN HEALTH
          RESORTS,INC/VITAL HEALTH TECHNOLOGIES, INC.
 (Exact
          name of small business issuer as specified in its charter)
 
 Minnesota
                41-1618186(State
                    or other jurisdiction of incorporation or organization)
                (I.R.S.
                    Employer Identification No.)


9454
        Wilshire Boulevard, Suite 600,
        Beverly Hills, CA 90212








Issuer's
      Telephone Number:  (310) 278-3108





Securities
      registered under Section 12(b) of the Act:  None





Securities
      registered under Section 12(g) of the Act:


Common
      Stock, par value 0.01





Check
      whether the issuer (1) filed all reports required to be filed by sections 13
      or
      15(d) of the Exchange Act during the past 12 months (or such shorter period
      that
      the issuer was required to file such reports), and (2) has been subject to
      such
      filing requirements for the past 90 days. Yes o No x





Check
      if
      there is no disclosure of delinquent filers in response to Item 405 of
      Regulation S-B in this form, and no disclosure will be contained, to the best
      of
      Registrant’s knowledge, in definitive proxy or information statements Incorporated
      by reference in Part III of this Form 10-KSB or any amendment to this
      Form
      10-KSB. o





The
      Registrant's revenues for its most recent fiscal year:  $30,785





The
      aggregate market value of the common equity held by non-affiliates based on
      the
      average bid and asked price as of November 1, 2007 was $ 5,982,006




As
      of
      November 1, 2007 the Registrant had outstanding 15,741,250 shares of common
      stock, par value $0.01.





Documents
      incorporated by reference:  None














TABLE
      OF
      CONTENTS





ITEMNUMBER
                AND
                CAPTIONPart
                I1.
            Description
                of Business2.
            Description
                of Property3.
            Legal
                Proceedings4.
            Submission
                of Matters to a Vote of Security HoldersPart
                II5.
            Market
                for Common Equity, Related
                Stockholder Matters and smallbusiness issues;
                purchases of
                equity securities6.
            Management's
                Discussion and Analysis or Plan of Operation7.
            Financial
                Statements8.
            Changes
                and Disagreements with
                Accountantson
                Accounting and Financial Disclosure8A.
            Controls
                and Procedures8B.
            Other
                InformationPart
                III9.
            Directors
                and Executive Officers of the Registrant.10.
            Executive
                Compensation11.
            Security
                Ownership of Certain Beneficial Owners and Management and Related
                Stockholder Matters.12.
            Certain
                Relationships and Related Transactions13.
            Exhibits14.
            Principal
                Accountant Fees and Services














PART
        I
 
 ITEM
        1.  DESCRIPTION OF
        BUSINESS
 
 Forward-Looking
        Statement
        Notice
 
 When
        used
        in this report, the words "may," "will," "expect," "anticipate," "continue,"
        "estimate," "project," "intend," and similar expressions are intended to
        identify forward-looking statements regarding events, conditions, and financial
        trends that may affect the Company's future plans of operations, business
        strategy, operating results, and financial position. Persons reviewing this
        report are cautioned that any forward-looking statements are not guaranteed
        of
        future performance and are subject to risks and uncertainties and that actual
        results may differ materially from those included within the forward-looking
        statements as a result of various factors. Such factors are discussed under
        the
        headings "Item 1. Description of Business”, "Item 6. Management's Discussion and
        Analysis or Plan of Operation" and also include general economic factors
        and
        conditions that may directly or indirectly impact the Company's financial
        condition or results of operations.
 
 General
 
 Caribbean
        American Health Resorts, Inc formerly Vital Health Technologies, Inc (the
        “Public Company”) or (“The Company”) was incorporated on April 11, 1960. On
        March 10,2003, the Public Company  consummated  an
        Agreement  and Plan of Reorganization to acquire all of the
        outstanding capital stock of Caribbean American Health Resorts, Inc (“CAHR”)a
        closely held private company, in exchange for 9,786,295 shares of the Public
        Company’s common stock(“CAHR transaction”). Prior to the CAHR transaction the
        Public Company sold off its remaining assets and operations and had 3,741,250
        shares of common stock issued and outstanding. Following the transaction,
        the
        Public Company changed its name from Vital Health Technologies, Inc to Caribbean
        American Health Resorts, Inc and had 13,527,545 shares of common stock issued
        and outstanding.
 
 The
        Company moved its headquarters to Beverly Hills, California. The current
        directors of Vital Health Technologies, Inc have resigned effective March
        18,
        2003 and Management and Board of Directors of Caribbean American Health Resorts,
        Inc have been appointed in their place.
 
 Caribbean
        American Health Resorts, Inc (a development stage company) plans to develop,
        own
        and operate world class health and longevity facilities ("resorts") in the
        Caribbean on the island of Barbados. The Health and Longevity
        facility  is intended to provide five star luxury accommodations and
        services for reconstructive surgery, detoxification and rehabilitation programs,
        spa and the company weight reduction programs, corporate wellness and a series
        of holistic health and longevity programs to promote and maintain a healthy
        mind
        and body. The resort will also offer tennis courts, mineral pools, and a
        full
        range of services such as body wraps, traditional massages and special services.
        Caribbean American Health Resorts, Inc will also distribute a variety of
        herbal
        based vitamins and dietary supplements.
 
 Caribbean
        American Health Resorts, Inc intends to be the global leader in providing
        herbal
        health products, premium spa treatments and reconstructive/elective surgical
        services (“Health Services”) to wealthy individuals in a luxury vacation
        destination setting.   The Health Services will be offered
        through the planned world class health and longevity facilities (“resorts”) in
        the Caribbean.  The company believes that the planned world class
        resorts in the Caribbean combined with the talent of leading surgeons and
        physicians from major cities in the United States will create a compelling
        value
        proposition for athletes, musicians, actors, entertainment artists and business
        executives seeking to escape from stress or fatigue or those seeking an ideal
        environment conducive to rapid recuperation after constructive/elective surgical
        procedures.
 
 The
        island of Barbados enjoys an excellent climate with temperatures of 66 to
        85
        degrees all year round. The island is serviced by all the major airlines
        from
        North America and Europe and is frequented by many jet setters. Since Barbados
        is a playground for the rich and famous, the company believes this targeted
        Health Services clientele will cherish the opportunity to be served in a
        location away from the discerning eyes of the media.
   1
 
 The
        island’s tourism industry is widely regarded as the primary catalyst to future
        economic growth. The Government of Barbados has a long history of being very
        accommodating to investment in the tourism industry and is very open to creating
        alliances with strategic partners to generate and protect employment in this
        industry.  As such, the company believes that environment would enable
        VITAL HEALTH to benefit from joint marketing opportunities with the Barbados
        Tourism Authority.
 
 Governmental
        Regulation
 
 The
        operation of a Health Resort on the island of Barbados  is
        subject  to several government regulations
        including  specific licensing  requirements for the doctors
        and surgeons as outlined by the Barbados  Medical Council and the
        Barbados Board Of Tourism. The Barbados Medical Council has recently approved
        licenses for some of the company’s surgeons and physicians to operate on the
        island.
 
 Competition
 
 There
        are
        hundreds of health spas and resorts worldwide. They all have special programs
        and atmosphere. The greatest competitors will be the facilities located in
        the
        United States of America which is the primary target. Palm Springs, California
        boasts a number of private spas with social menus and programs for the most
        discerning clientele. Caribbean American Health Resorts intends to offer
        a more
        specialized service to the industry.  This service will include most
        of those services offered by the competitors. CAHR’s focus will be concentrated
        on a more medically equipped facility with emphasis on reconstructive surgery
        and elective surgery, detox programs and corporate the wellness, totally
        carried
        by specialists and advanced trained professionals in the particular
        discipline.
 
 Employees
 
 Caribbean
        American Health Resorts has two full time employees.
 
 ITEM
        2.  DESCRIPTION OF PROPERTY
 
 The
        Company leases approximately 700 square feet of office space in Beverly Hills,
        California, paying $ 1,800 per month on a month-to month basis. We believe
        that
        these facilities are adequate to conduct our current operations and we do
        not
        expect to seek additional administrative offices for the next 12
        months.
 
 ITEM.3  LEGAL
        PROCEEDINGS
 
 The
        Company is not a party to any legal proceedings and to the best of its
        knowledge, no such proceedings by or against the Company has been
        threatened.
 
 ITEM
        4.  SUBMISSION OF
        MATTERS TO A VOTE OF SECURITY HOLDERS
 
 There
        were no matters submitted to a vote of security holders during the fiscal
        year
        ended 2006 as covered by this report on form 10-KSB.
 
 
 2
 
 PART
        II
 
 
 ITEM
        5.  MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER
        MATTERS
 
 Caribbean
        American Health Resorts, Inc common stock trades on the Pink Sheets under
        the
        ticker symbol CAHR.PK. There are currently 5 market makers for the Company's
        stock. The trading volume has been low due to several factors including general
        market conditions and limited resources for the Company to implement its
        business plan. With the recent acquisition agreement with Caribbean American
        Health Resorts, Inc and improved market conditions, the trading volume for
        the
        stock should improve; however, there is no assurance that trading volume
        will
        improve in the future. Even if trading volume market should improve, there
        is no
        way of determining what the market price may be at any future time.
 
 The
        following table shows the range of closing bid prices for the company’s Common
        Stock in the over-the-counter market for the calendar quarters
        indicated.  The quotations represent prices in the over-the-counter
        market between dealers in securities, do not include retail mark-up, mark-down,
        or commissions and do not necessarily represent actual transactions. [Internet
        Yahoo Finance)
  BID
          PRICES
  2006
                  
                  High
                      Bid
                  Low
                      BidJan.1
                      through Mar.31
                  First
                      Quarter
                  0.22
                  0.10Apr.1
                      through Jun.30
                  Second
                      quarter
                  0.15
                  0.07Jul.1
                      through Sep.30
                  Third
                      quarter
                  0.15
                  0.06Oct.1
                      through Dec.31
                  Fourth
                      quarter
                  0.15
                  0.10
  2005
                
                High
                    Bid
                Low
                    BidJan.1
                    through Mar.31
                First
                    Quarter
                0.26
                0.13Apr.1
                    through Jun.30
                Second
                    quarter
                0.15
                0.08Jul.1
                    through Sep.30
                Third
                    quarter
                0.15
                0.06Oct.1
                    through Dec.31
                Fourth
                    quarter
                0.14
                0.10
 
 At
        November 1, 2007 there were approximately 956 holders of record of the Company's
        15,741,250 issued and outstanding shares of common stock at $0.01 par
        value.
 
 The
        Company has never declared a cash dividend on its Common Stock. The Company
        has
        not paid, nor declared, any cash dividends since its inception and does not
        intend to declare any such dividends in the foreseeable future. The Company's
        ability to pay dividends is subject to limitations imposed by Minnesota
        law.
 
 Merger
        with Caribbean American Health
        Resorts, Inc.
 
 Caribbean
        American Health Resorts, Inc formerly Vital Health Technologies, Inc (the
        “Public Company”) or (“The Company”) was incorporated on April 11, 1960. On
        March 10, 2003, the Public Company  consummated  an
        Agreement  and Plan of Reorganization to acquire all of the
        outstanding capital stock of Caribbean American Health Resorts, Inc (“CAHR”)a
        closely held private company, in exchange for 9,786,295 shares of the Public
        Company’s common stock(“CAHR transaction”). Prior to the CAHR transaction the
        Public Company sold off its remaining assets and operations and had 3,741,250
        shares of common stock issued and outstanding. Following the transaction,
        the
        Public Company changed its name from Vital Health Technologies, inc to Caribbean
        American Health Resorts, Inc and had 13,527,545 shares of common stock issued
        and outstanding.
 
 The
        Company moved its headquarters to Beverly Hills, California. The current
        directors of Vital Health Technologies, Inc have resigned effectively March
        18,
        2003 and Management and Board of Directors of Caribbean American Health Resorts,
        Inc have been appointed in their place.
   3
  ITEM
        6. MANAGEMENT'S DISCUSSION AND
        ANALYSIS OR PLAN OF OPERATION
 
 BUSINESS
        STRATEGY
 
 Caribbean
        American Health Resorts’ objective is to maximize its profitability by providing
        quality health products, high quality spa treatment and elective/reconstructive
        surgical services as well as distributing a variety of herbal based vitamins
        and
        dietary supplements.  The key elements of the strategy
        are:
 
 ·
              Establish
                  a World-Class Health
                  Resort
  CAHR  has
        identified prime property, on the island of Barbados, on which it intends
        to
        build a world-class health resort that will cater to the spa treatment,
        constructive/elective surgical and other alternative medical needs of athletes,
        musicians, actors, entertainment artists and business executives through
        out the
        world.  The company will combine the ideal climate on the island of
        Barbados with the expertise of leading surgeons and physicians from the United
        States to deliver high quality health services to these targeted clients
        in the
        comfort of a luxury resort. The Barbados Medical Council has recently approved
        the license for the surgeons to operate on the island.
 
 ·
              Market
                    the products and
                    services aggressively to target
                    Customers
  CAHR intends
          to market its health services aggressively to business executive, sports
          and
          entertainment clients worldwide as well as targeted Caribbean
          population.  In January 2005, CAHR launched a new herbal product line.
          The line consists of a variety of herbal based vitamins and dietary supplements.
          The multi-vitamins are claimed to be manufactured from the finest
          pharmaceutical–grade nutrients and based on the latest scientific
          research.
 
 ·
              Implement
                  a Discipline
                  Financial Strategy
  CAHR
‘s
        financial strategy will be focused on maximizing profitability and minimizing
        financial risks.  To this end, the company will focus on achieving the
        right balance between equity and debt in the capital structure to ensure
        that
        CAHR maintains adequate financial flexibility to adjust successfully to changes
        in the market place.  The company believes that a disciplined
        financial approach will also enable us to capitalize on opportunistic expansion
        opportunities throughout the Caribbean.
 
 ·
              Liquidity
                  and Capital
                  resources
 
 The
        company expects that its cash and cash generated from operations will be
        insufficient to meet its operating cash needs. The company will continue
        to rely
        on Mr. Martin and other shareholders for working capital support for the
        company. The company will attempt to raise capital for its acquisitions and
        development through a private placement or rights offering of the company‘s
        common stock. There can be no assurance that the company will be able to
        raise
        the required amount of capital to successfully complete its plan.
 
 Year
        Ended December 31, 2006 and
        December 31, 2005
 
 The
          Company generated $30,785 for the year ended December 31, 2006 as compared
          to
          $66,643 revenue for the same period December 2005. Cost of Sales for the
          year
          ended December 31, 2006 and 2005 were $15,501 and $33,122 respectively.
          This
          change (reduction) in Revenue and Cost of Sales was caused by the fact
          that one
          of our major supplier closed its doors. However, we have since secured
          a new
          supplier for the products and expect to see an increase in sales over the
          next
          quarters.
 
 General
          and Administrative expenses for the year ended December 31, 2006 were $255,456
          as compared to $223,869 the same period of 2005. This change in General
          and
          Administrative expenses was due to an increase in market and promotion
          to
          generate new revenue for the company.
 
 The
        Company had interest expense in the amount of $134,371 for the year ended
        December 31, 2006 as compared to the interest expense of $113,242 for the
        year
        ended December 31, 2005. This interest expense is related to the long term
        debt
        of $1,000,000 borrowed.
 
 As
        result
        of the foregoing, the company realized a net loss of $375,339 for the year
        ended
        December 31, 2006 as compared to a net loss of $285,088 for the same period
        2005.
   4
  OFF-BALANCE
        SHEET
        ARRANGEMENTS
 
 The
        company has no off-balance sheet arrangements that have or are reasonably
        likely
        to have current or future effect  on the company’s financial
        condition, changes in financial condition, revenues or expenses, results
        of
        operations, liquidity, capital expenditure or capital resources.
 
 RISK
        FACTORS
 
 The
        company is subject to various risks that may materially harm the business,
        financial condition and results of operations. If any of these
        risks
        or uncertainties actually occurs, the business, financial condition or operating
        results could be materially harmed.
  
 The
        Company has incurred significant
        and continuing losses and may not be able to generate revenues to sustain
        the
        operations.
 
 The
        Company incurred net losses of approximately $375,339 and $285,088 for the
        years
        ended December 31, 2006 and 2005, respectively, and $8,762,052 for the period
        from inception through December 31, 2006. The Company will continue to have
        a
        high level of operating expenses and will be required to make significant
        up-front expenditures in connection with the commencement of income-generating
        activities (including, but not limited to, salaries of executive, marketing,
        and
        other personnel). The Company expects to incur additional losses until such
        time
        as it is able to generate sufficient revenues to finance its operations and
        the
        costs of expansion. There can be no assurance that the Company will be able
        to
        generate such revenues and operate profitably.
 
 The
        Company has an immediate need for
        additional financing.
 
 The
        Company has limited operating funds and has nominal cash on hand. The Company
        has an immediate need for funds in order to finance its business operations.
        As
        of December 31, 2006, the Company had a working capital deficit of approximately
        $1,297,000. The working capital requirements in the foreseeable future will
        depend on a variety of factors, including the Company's ability to implement
        its
        business plan. In the event that the plans change, the assumptions change
        or
        prove to be inaccurate, or the cash flow proves to be insufficient to fund
        the
        operations (due to unanticipated expenses, delays, problems, difficulties
        or
        otherwise), the company will be required to seek additional financing sooner
        than anticipated or have to curtail its activities. The Company has secured
        a
        loan of $1,000,000 of short-term indebtedness as of December 31, 2003. To
        the
        extent that it incurs additional indebtedness or any other transaction, the
        company will be subject to risks associated with incurring substantial
        indebtedness, including the risks that interest rates may fluctuate and cash
        flow may be insufficient to pay principal and interest on any such indebtedness.
        The company currently has no sources of revenue from which to repay the
        indebtedness. The Company has no current arrangements with respect to, or
        sources of, additional financing. There can be no assurance that additional
        financing will be available to the company on commercially reasonable or
        acceptable terms, if at all. The ability to obtain additional capital will
        be
        dependent on market conditions, the national economy and other factors outside
        of the company’s control. The failure to secure necessary financing would have a
        material adverse effect on the company and could require the company to delay
        or
        modify its business plan.
 
 The
        limited operating history
        subjects the company to the risks of a new business
 
 The
        Company has a limited operating history upon which to evaluate the future
        performance and prospects. The prospects must be considered in light of the
        risks, expenses, delays, problems and difficulties frequently encountered
        in the
        establishment of a new business in the Health Care and Hospitality Industry,
        which is an evolving industry characterized by intense competition.
 
 There
        may be potential liabilities
        associated with the company which were not discovered at the time of the
        merger.
  The
        Company may have liabilities that were not discover or may have been unable
        to
        discover during the pre-acquisition investigation. Any indemnities or warranties
        may not fully cover such liabilities due to their limited scope, amount or
        duration, the financial limitations of the indemnitor or warrantor, or for
        other
        reasons.
   5
  Therefore,
        in the event the company is held responsible for the foregoing liabilities,
        the
        Company's operations may be materially and adversely affected.
 
 The
        ability to attract and retain
        customers depends on factors the company cannot control.
 
 The
        ability to attract customers, and the ability of the company to retain
        customers, will depend on a number of factors, many of which are beyond the
        control. These factors include:
 
 The
        market for the services is characterized by rapid technological advances,
        evolving industry standards, changes in customer requirements and frequent
        new
        product and service introductions and enhancements. The industry is
        characterized by frequent introduction of new products and services. In order
        for us to achieve market acceptance for the products and services, the company
        require substantial marketing efforts and the expenditure of significant
        funds
        to create both awareness and demand by marketing retailers and consumers.
        If
        technologies or standards applicable to the products or services become obsolete
        or fail to gain widespread consumer acceptance and the company is unable
        to
        adapt to such changes, then the business and financial results will be
        materially and adversely affected.
 
 The
        company operates in an extremely
        competitive market and may not be able to compete
        effectively.
  The
        current and prospective competitors are numerous. The Health Care services
        business is highly competitive and there are few significant barriers to
        entry.
        All of the established competitors have substantially greater financial,
        technical, marketing, distribution, personnel and other resources, larger
        customer bases, longer operating histories, greater name recognition and
        more
        established relationships in the industry than the company do. If the
        marketplace substantially expands and becomes commercially viable, then any
        of
        these competitors may expand their services and seek to dominate the
        marketplace, thereby preventing us from obtaining any meaningful market share.
        The company intends to compete on the terms of price, customer support,
        technical expertise, variety of value added services and
        reliability.
 
 Absence
        of
        dividends
  The
        Company has never paid any dividends on shares of the common stock and does
        not
        anticipate that the company will pay dividends in the foreseeable future.
        The
        company intends to apply any earnings to fund the development of the business.
        Investment in the Company is inappropriate if you are seeking current or
        near
        term income.
  The
        management has the ability to
        control almost all matters.
 
 Halton
        Martin Chief Operating Officer and Chief Financial Officer owns approximately
        60% of the Company's shares of common stock as of November 1, 2007. Therefore,
        he has the ability to elect the directors and to control the outcome of other
        issues submitted to the stockholders.
 
 Difficulty
        of trading and obtaining
        quotations for the common stock.
  The
        common stock is currently quoted on the Pink Sheets under the symbol “CAHR.PK.”
As a result of trading in the over-the-counter market, an investor would
        likely
        find it more difficult to purchase, dispose of, or to obtain quotations as
        to
        the price of the common stock. There can be no assurance that a more active
        trading market will develop, or if developed, that it will be
        maintained.
  Penny
        Stock regulation is expected to
        adversely affect the market for the Company's securities.
  The
        trading of the common stock is currently subject to Rule 15g-9 promulgated
        under
        the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, for
        non-NASDAQ and non-exchange listed securities. Under such rule, brokers-dealers
        who recommend such securities to persons other than established customers
        and
        accredited investors must make a special written suitability determination
        for
        the purchaser and receive the purchaser's written agreement to a transaction
        prior to sale. Securities are exempt from this rule if the market price is
        at
        least $5.00 per share.
   6
 
 The
        Commission has adopted regulations that generally define a “penny stock” to be
        an equity security that has a market price of less than $5.00 per share or
        an
        exercise price of less than $5.00 per share subject to certain exceptions.
        Such
        exceptions include equity securities listed on NASDAQ and equity securities
        issued by an issuer that has (i) net tangible assets of at least $2,000,000,
        if
        such issuer has been in continuous operation for more than three years, or
        (ii)
        net tangible assets of at least $5,000,000, if such issuer has been in
        continuous operation for less than three years, or (iii) average revenue
        of at
        least $6,000,000 for the preceding three years. Unless an exception is
        available, the regulations require the delivery, prior to any transaction
        involving a penny stock, of a risk disclosure schedule explaining the penny
        stock market and the risks associated therewith.
  The
        common stock is currently a penny stock as defined in the Exchange Act and,
        as
        such, the market liquidity for the Common Stock is limited to the ability
        of
        broker-dealers to sell common stock in compliance with the abovementioned
        disclosure requirements.
  ITEM
        7.  FINANCIAL
        STATEMENTS
 
 The
        financial statements of the Company appears at the end of this report beginning
        with the Index to Financial Statements on page 16.
 
 ITEM
        8. CHANGES IN AND DISAGREEMENTS
        WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
 
 As
        part of the Share Exchange Agreement dated March 10, 2003 between Vital Health
        Technologies, Inc and Caribbean American Health Resorts, Inc the new directors
        added Beutel Accountancy Corporation as accountants and auditors.
 
 (i)
        On
        May 20, 2005, Beutel Accountancy Corporation (“Beutel”) was dismissed as
        independent auditor for the Company. On May 20, 2005, the Company engaged
        Farber
        Hass Hurley & McEwen, LLP (formerly Farber & Hass LLP) (“Farber”) as its
        principal independent accountant. This decision to engage Farber was ratified
        by
        the majority approval of the Board of Directors of the Company. On June 09,
        2006
        Farber notified the Company that they currently do not have the manpower
        to
        continue with the audit at this time and therefore has resigned as the Company’s
        auditors. On June 16, 2006, the Company agreed to terminate Farber as its
        principal independent accountant and engaged De Joya Griffith & Company, LLC
        as its principal independent accountant. This decision to engage De Joya
        Griffith & Company, LLC was ratified by the majority approval of the Board
        of Directors of the Company.
  (ii)
        Management of Vital Health Technologies, Inc. (“Vital Inc.”) has not had any
        disagreements with Beutel related to any matter of accounting principles
        or
        practices, financial statement disclosure or auditing scope or procedure.
        For
        the two most recent fiscal years and any subsequent interim period through
        Beutel’s termination on May 20, 2005, there has been no disagreement between the
        Company and Beutel on any matter of accounting principles or practices,
        financial statement disclosure, or auditing scope or procedure, which
        disagreement, if not resolved to the satisfaction of Beutel would have caused
        it
        to make a reference to the subject matter of the disagreement in connection
        with
        its reports. Also Management of Vital Health Technologies, Inc. (“Vital Inc.”)
        has not had any disagreements with Farber related to any matter of accounting
        principles or practices, financial statement disclosure or auditing scope
        or
        procedure. Farber has not issued any report on our financial statements since
        they were engaged.
  (iii)
        The
        Company’s Board of Directors participated in and approved the decision to change
        independent accountants. Firstly, the decision to change Beutel was based
        on a
        request from the SEC, as noted in their letter dated May 3, 2005. This change
        was made solely because Beutel is not registered with the PCAOB and for no
        other
        reasons. Beutel’s audit report for either of the past two years contained no
        adverse opinion or disclaimer of opinion and was not qualified or modified
        as to
        audit scope or accounting principles, except for the going concern opinion
        issued in the audit report.
 
 Secondly,
        the decision to change Farber was made only at their request based on the
        fact
        that they were unable to continue the audit at this time due to the lack
        of
        sufficient personnel and for no other reason.
   7
  (iv)
        In
        connection with its review of financial statements through May 20, 2005,
        there
        have been no disagreements with Farber on any matter of accounting principles
        or
        practices, financial statement disclosure, or auditing scope or procedure,
        which
        disagreements if not resolved to the satisfaction of Farber would have caused
        them to make reference thereto in their report on the financial
        statements.
  (v)
        During the most recent audit period and the interim period subsequent to
        May 20,
        2005, there have been no reportable events with the Company as set forth
        in Item
        304(a)(i)(v) of Regulation S-K.
  (vi)
        The
        Company requested that Farber furnish it with a letter addressed to the SEC
        stating whether or not it agrees with the above statements. A copy of such
        letter is filed as an Exhibit to the Form 8-K.
 
 (2)   New
        Independent Accountants:
  (i)
        The
        Company engaged, De Joya Griffith & Company, LLC, of Henderson, Nevada, as
        its new independent auditors as of June 16, 2006. Prior to such date, the
        Company did not consult with De Joya Griffith & Company, LLC regarding (i)
        the application of accounting principles, (ii) the type of audit opinion
        that
        might be rendered De Joya Griffith & Company, LLC (iii) any other matter
        that was the subject of a disagreement between the Company and its former
        auditor as described in Item 304(a)(1)(iv) of Regulation S- B.
  There
        have been no other changes in or disagreements with accountants during the
        last
        three fiscal years.
 
 ITEM
        8A.  CONTROLS AND
        PROCEDURES
 
 The
        Company's Chief Executive Officer/Chief Financial Officer has
        conducted an evaluation of the Company's disclosure controls and procedures
        as
        of December 31, 2006.  Based on their evaluation, the Company's Chief
        Executive Officer/Chief Financial Officer has concluded that the Company’s
        disclosure controls and procedures are effective to ensure that information
        required to be disclosed by the Company in reports that it files or submits
        under the Securities Exchange Act of 1934 is recorded, processed, summarized
        and
        reported within the time periods specified in the applicable Securities and
        Exchange Commission rules and forms.  There were no significant
        changes in the Company's internal controls or in other factors that could
        significantly affect these controls subsequent to the date of the most recent
        evaluation of these controls by the Company's Chief Executive Officer/Chief
        Financial Officer.  No significant deficiencies or material the
        company weaknesses in the Company's internal controls were identified therefore
        no corrective actions were taken.
 
 
 8
 
 
 PART
        III
 
 
 ITEM
        9.  DIRECTORS AND
        EXECUTIVE OFFICERS OF THE REGISTRANT,
 
 Directors
        and Officers
 
 The
        following table sets forth the names, ages, and positions with the Company
        for each of the officers and directors of the Company.
  Name
                Age
                Position
                Director
                      and Officer SinceHalton
                    Martin
                59
                Chief
                    Executive Officer, Chief Operating Officer and President
                March,
                    2003Dr.
                    Orlando Pile
                59
                Director
                March,
                    2003Paul
                    Meye
                64
                Director
                    and Vice President of Finance
                March,
                    2003Dr.
                    David Waldron
                58
                Director
                    and Vice President
                March,
                    2003
  All
        directors hold office until the next annual meeting of stockholders or until
        their successors are duly elected and qualify. Officers serve at the discretion
        of the Board of Directors. The company is presently conducting negotiations
        with
        three former securities specialists to serve as officers of the
        company.
 
 The
        following is information on the business experience of each director and
        officer.
 
 Halton
        Martin is the President, Chief Operating Officer and Chief Executive Officer
        of
        the company. He has over 20 years experience in the business and financial
        industry. Mr. Martin served as President of the Royal Caribbean Hotel
        Corporation in Barbados. During that period, Mr. Martin gained extensive
        experience in the marketing, financial and business operations in the
        hospitality industry. Mr. Martin owned and operated a full line insurance
        agency
        and was General Agent for California Western States Life Insurance Company
        in
        Sacramento, California. He was a licensed registered representative with
        the
        National Association of Security Dealers from 1972 to 1983 and was associated
        with several brokerage firms nationally. Mr. Martin has spent several years
        working with the young resident physicians at the Martin Luther King Hospital
        and Harbor General Hospitals in California. He developed many financial programs
        for doctors. In 1995, Mr. Martin became the Secretary of the Board of Trustees
        for Quantum University. This University is a chiropractic facility with studies
        in the areas of alternative medicine. He also became Vice President of the
        Business Development for the said University. Mr. Martin has been involved
        in
        the politics of the Caribbean and took part in the 1990 general election.
        He has
        spoken at many business seminars and was a featured speaker at the CACCI
        Annual
        Conference in New York's World trade center on "Doing Business in the Caribbean"
        in 1994. Mr. Martin is a member of the American of the Association of Governing
        Boards of Universities and Colleges. Mr. Martin holds a Bachelor of Science
        degree in Accounting and Finance from Devry University in Southern California.
        Mr. Martin has extensive experience in dealing with all types of investors,
        underwriters, physicians and industry personnel.
  Dr.
        Orlando Pile collaborates with physicians of Alternative Medicine to promote
        methods of enhancing the Immune System and improving Nutrition. He speaks
        to
        many organizations and Universities throughout the United States, Canada
        and the
        Caribbean. As a physician specialist for the Los Angeles County Sheriff’s
        Department, Dr. Pile is the Chief of Communicable Diseases. Having worked
        with
        the Department of Justice on numerous projects, he is at the forefront of
        this
        specialty. In addition, the doctor is a member of the distinguished faculty
        of
        Correctional Physicians on HIV/AIDS. He has lectured extensively and
        participated in many conferences on Infectious Diseases in the correctional
        sector, as well as the community at large. Currently he collaborates with
        physicians of Alternative Medicine in an effort to promote ways of enhancing
        the
        Immune System and improving nutrition. In addition to this, the doctor still
        finds time for the local community by offering his services to sports medicine
        in the youth and high school football programs. The doctor is a senior member
        of
        the medical staff of Robert F. Kennedy Medical Center in Hawthorne, as well
        as
        Centinela Hospital Medical Center in Inglewood, and maintains a very successful
        practice in Inglewood and Los Angeles, California.
   9
 
 Paul
          Meye
          is the Vice President of Finance and Director for the corporation. He is
          a tax
          accountant who lives in Orange County and has practiced for thirty years.
          His
          practice boasts a number of clients from across the United States and several
          foreign countries.
 
 Dr.
          David
          Waldron is Vice President and Director and will oversee medical operations
          as a
          Director of the corporation. He is a surgeon with 20 years experience within
          the
          specialty of ophthalmology. Dr. Waldron works with several programs for
          the
          state of California and oversees an independent group of physicians
          (IPA).
 
 Compliance
        with
        Section 16(a) of the Exchange Act
  Pursuant
        to Section 16 of the Securities Exchange Act of 1934, our directors and
        executive officers and beneficial owners of more than 10% of our common stock
        are required to file certain reports, within specified time periods, indicating
        their holdings of, and transactions in, the common stock and derivative
        securities. Based solely on a review of such reports provided to us and written
        representations from such persons regarding the necessity to file such reports,
        we are not aware of any failures to file reports or report transactions in
        a
        timely manner during the fiscal year ended December 31, 2006.
  Code
        of Ethics
 
 We
        have
        adopted a Code of Business Conduct and Ethics designed to comply with Item
        406
        of Regulation S-B. A copy of our Code of Business Conduct and Ethics is filed
        as
        an exhibit to our Annual Report on Form 10-KSB for December 31, 2003. We
        will
        provide a copy of the Code of Ethics, without charge, to any person who sends
        a
        written request addressed to the company at 9454 Wilshire Blvd, Suite 600,
        Beverly Hills, CA. 90212.
  ITEM
        10.  EXECUTIVE COMPENSATION
 
 Summary
        Cash and Other Compensation
 The
        following table shows, for fiscal year 2006 the cash compensation paid by
        the
        company as well as certain other compensation paid accrued for those years,
        to
        Halton Martin, the company’s chief Executive Officer
  Name
                      and
                      address
                  Of
                      beneficial
                      owner
                Year
                Salary
                Bonus
                OptionsHalton
                    Martin
                2006
                $0
                $0Director/President/CEO/COO
                2003
                $0
                $0Dr
                    Orlando Pile
                2006
                $0
                $0Director
                2003
                $0
                $0Paul
                    Meye
                2006
                $0
                $0Director
                    and VP of Finance
                2003
                $0
                $0Dr
                    David Waldron
                2006
                $0
                $0Director
                    and VP
                2003
                $0
                $0
  Mr.
        Martin was appointed an executive officer in March 2003.
   10
  
 ITEM
        11.  SECURITY
        OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
        MATTERS
 
 The
        following table sets forth as of November 1, 2007, the number and percentage
        of
        the 15,741,250 issued and outstanding shares of the Company's common stock,
        par
        value $0.01, which according to the information supplied to the Company,
        the
        company beneficially owned by (i) each person who is currently a director
        of the
        Company, (ii) each executive officer, (iii) all current directors and executive
        officers of the Company as a group and (iv) each person who, to the knowledge
        of
        the Company, is the beneficial owner of more than 5% of the outstanding common
        stock. Except as otherwise indicated, the persons named in the table have
        sole
        voting and dispositive to the company with respect to all shares beneficially
        owned, subject to community property laws where applicable.
  Name
                      and Addressof Beneficial Owner
                Common
                    Shares
                Percent
                    of ClassHalton
                    Martin
                9,000,000
                60
 Equity
        Compensation Plan Table
 
 The
        following table sets forth aggregate information regarding grants under all
        equity compensation plans of the company as of December 31, 2006:
 
 Number
                    of Securities to be
                  Issued
                    upon Exercise of
                  outstanding
                    options,
                  Warrants
                    and
                    rights
                Weighted
                    Average
                  exercise
                    price of
                  outstanding
                    options,
                  Warrants
                    and
                    rightsPlan
                    Category
                (a)
                (b)Equity
                    compensation plans
                0
                $0approved
                    by security shareholdersEquity
                    compensation plans not
                0
                $0approved
                    by security shareholdersTotal
                0
                $0
 ITEM
        12.    CERTAIN RELATIONSHIPS AND RELATED
        TRANSACTIONS
  There
        are
        continued borrowings and repayments from certain shareholders.
   11
  ITEM
        13.  EXHIBITS
 
 Exhibits
 
 Copies
        of
        the following documents are included as exhibits to this report pursuant
        to Item
        601 of Regulation S-B.
 
 Exhibit
        Index
 
 SEC
                  Ref. No.Exhibit   3.1
                Articles
                    of Incorporation.*Exhibit   3.2
                Bylaws.*Exhibit   4.1
                Agreement
                    and Plan of Share Exchange.**Exhibit  10.1
                Settlement
                  AgreementExhibit  10.2
                Non-Exclusive
                  License AgreementExhibit   14
                Code
                    of Ethics.***Exhibit  31.1
                Certification
                    of Principal Executive Officer and Principal
                    Financial Officer pursuant to Section 302 ofSarbanes
                    Oxley Act of 2002Exhibit  32.1
                Certification
                    of Principal Executive Officer and Principal
                    Financial Officer pursuant to Section 906 ofSarbanes
                    Oxley Act of 2002
 *    These
            items were filed as
            exhibits to the Company's annual report on Form 10-KSB for the year ended
            December 31, 2000, and are incorporated herein by this reference.
 
 **       
            These items the company filed as exhibits to the Company's annual report
            on Form
            10-KSB for the year ended December 31, 2002, and are incorporated herein
            by this
            reference.
 
 ***     
            This item was filed as an exhibit to the Company's annual report on Form
            10-KSB
            for the year ended December 31, 2003, and is incorporated herein
            by  this reference.
 
 12
  
 ITEM
        14.    PRINCIPAL ACCOUNTANT FEES AND
        SERVICES
 
 Audit
          Fees
 
 The
          aggregate fees billed for professional services rendered by De Joya Griffith
          & Company LLC for the audit of the Company's annual financial statements
          for
          fiscal years 2005 and 2006 is $18,000 and $50,000, respectively.
 
 Audit-Related
          Fees
 
 The
          aggregate fees billed in fiscal years 2005 and 2006 for assurance and related
          services by De Joya Griffith & Company LLC related to the performance of the
          audit or review of the Company's financial statements was $-0- and $18,000,
          respectively.  The nature of those services was audit services, annual
          reports, quarterly reports and accounting consultations in connection with
          the
          merger acquisitions.
 
 All
          Other
          Fees
 
 The
          company was also billed $29,000 in fiscal years 2005 and 2006 for professional
          services rendered by Faber & Hass Accountancy Corporation for other products
          or services.
 
 The
          Company has not formally designated an audit committee and as a result,
          the
          entire board of directors performs the duties of an audit
          committee.  It's the Board's policy to pre-approve all services
          provided by The Accountancy Corporation effective as of April 1,
          2002.  Since all services provided by the principal accountant are
          pre-approved, the Company does not rely on pre-approval policies and
          procedures.
 
 
 SIGNATURES
 
 In
        accordance with the requirements of the Exchange Act, the registrant caused
        this
        report to be signed on its behalf by the undersigned, thereunto duly
        authorized.
  Caribbean
                    American Health
                    Resorts, IncDate:
                    January 8, 2007
                By: /s/
                    Halton MartinHalton
                    Martin Martin, Chief Executive
                    Officer
 
 
 
 13
 CARIBBEAN
            AMERICAN HEALTH RESORTS,
            INC.
 (A
            Development Stage
            Company)
  Consolidated
            Financial
            Statements
 December
            31,
            2006
     
      CARIBBEAN
          AMERICAN HEALTH RESORTS,
          INC.
   
  REPORT
                    OF INDEPENDENT
                    REGISTERED PUBLIC ACCOUNTING FIRM
                F-1BALANCE
                    SHEET
                F-2STATEMENTS
                    OF
                    OPERATIONS
                F-3STATEMENTS
                    OF CASH
                    FLOWS
                F-4STATEMENT
                    OF STOCKHOLDERS’
                    DEFICIT
                F-5NOTES
                    TO FINANCIALS
                    STATEMENTS
                F-6
      
     Report
          of Independent registered Public Accounting Firm
 
 To
          the
          Board of Directors and Stockholders
 Caribbean
          American Health Resorts, Inc.
 (A
          Development Stage Company)
 Beverly
          Hills, California 90212
 
 We
          have
          audited the accompanying balance sheet of Caribbean American Health Resorts,
          Inc. (A
          Development Stage Company) of December 31, 2006 and the related statements
          of
          operations, stockholders’ equity (deficit) and cash flows for the years ended
          December 31, 2006, 2005, and for the period from Inception (September 17,
          1998)
          to December 31, 2006. These financial statements are the responsibility
          of the
          Company’s management. Our responsibility is to express an opinion on these
          financial statements based on our audit.
 
 We
          conducted our audit in accordance with the standards of the Public Company
          Accounting Oversight Board (United States). Those standards require that
          we plan
          and perform the audit to obtain reasonable assurance about whether the
          financial
          statements are free of material misstatement (examining on a test basis,
          evidence supporting the amounts and disclosures in the financial statements.)
          We
          believe that our audits provide a reasonable basis for our opinion.
 
 In
          our
          opinion, the financial statements referred to above present fairly, in
          all
          material respects, the financial position of Caribbean American Health
          Resorts,
          Inc. (A Development Stage Company) as of December 31, 2006 and the related
          statements of operations, stockholders’ equity (deficit) and cash flows for the
          years ended December 31, 2006,
          2005, and for the period from Inception (September 17, 1998) to December
          31,
          2006 in conformity with accounting principles generally accepted in
          the
          United States of America.
 
 
 
 
 /s/
          De
          Joya Griffith & Company, LLC
 Henderson,
          Nevada
 January
          8, 2008
    F-1
  CARIBBEAN
                    AMERICAN HEALTH RESORTS, INC.(A
                    Development Stage Company)Balance
                    SheetDecember
                    31, 2006ASSETSCurrent
                    assetsCash
                      and equivalents
                
                $
                7,408Inventory
                
                
                3,854Total
                      current
                      assets
                
                
                11,262Equipment,
                      net
                
                
                1,913Deposits
                
                
                205,511Total
                      assets
                
                $
                218,686LIABILITIES
                      AND SHAREHOLDERS'
                      DEFICITCurrent
                    liabilitiesAccounts
                      payable
                
                
                100,955Accrued
                    expenses
                
                
                10,054Accrued
                      interest
                
                
                366,329Advance
                    from stockholder
                
                
                22,150Other
                      current liabilities - line of credit
                
                
                14,007Note
                    payable
                
                
                1,000,000Total
                      current
                      liabilities
                
                
                1,513,495Commitments
                      and contingencies
                
                
                -Shareholders'
                      deficitCommon
                    stock, 50,000,000 shares authorized, $.01 par value,15,095,293
                      shares issued and outstanding
                
                
                150,953Additional
                      paid-in capital
                
                
                7,330,282Treasury stock
                
                
                (13,992
                )Deficit
                    accumulated during the development stage
                
                
                (8,762,052
                )Total
                      shareholders'
                      deficit
                
                
                (1,294,809
                )Total
                    liabilities and
                    shareholders’ deficit
                
                $
                218,686
    The
        accompanying notes are an integral part of these financial
        statements.
    F-2
  CARIBBEAN
                    AMERICAN HEALTH RESORTS, INC.(A
                    Development Stage Company)Statement
                    of OperationsCumulativefrom
                    inception(September
                    17, 1998)Year
                    ended December 31,
                
                
                to
                    December 31,2006
                
                
                2005
                
                
                2006Revenue
                
                $
                30,785
                
                
                $
                66,643
                
                
                $
                112,566Cost
                    of revenue
                
                
                15,501
                
                
                
                33,122
                
                
                
                48,623Gross
                    profit
                
                
                15,284
                
                
                
                33,521
                
                
                
                63,943Operating
                    costs and expenses:General
                    and administrative
                
                
                255,456
                
                
                
                223,869
                
                
                
                2,148,138Loss
                    on settlement of obligations
                
                
                -
                
                
                
                -
                
                
                
                4,509,263Total
                    operating costs and expenses
                
                
                255,456
                
                
                
                223,869
                
                
                
                6,657,401Loss
                    from operations
                
                
                (240,172
                )
                
                
                (190,348
                )
                
                
                (6,593,458
                )Other
                    income (expense)Interest
                    income
                
                
                4
                
                
                
                18,502
                
                
                
                41,061Interest
                    expense
                
                
                (134,371
                )
                
                
                (113,242
                )
                
                
                (2,204,855
                )Other
                    income
                
                
                -
                
                
                
                -Total
                    other income (expense)
                
                
                (134,367
                )
                
                
                (94,740
                )
                
                
                (2,163,794
                )Loss
                    before provision for income taxes
                
                
                (374,539
                )
                
                
                (285,088
                )
                
                
                (8,757,252
                )Provision
                    for income taxes
                
                
                800
                
                
                
                -
                
                
                
                4,800Net
                    loss
                
                $
                (375,339
                )
                
                $
                (285,088
                )
                
                $
                (8,762,052
                )Basic
                    and diluted net loss per share
                
                $
                (0.02
                )
                
                $
                (0.02
                )Basic
                    and diluted weighted average numberof
                    common shares outstanding
                
                
                15,093,256
                
                
                
                15,083,793
  The
          accompanying notes are an integral part of these financial
          statements.
   F-3
  
 CARIBBEAN
                    AMERICAN HEALTH RESORTS, INC.(A
                    Development Stage Company)Statement
                    of Shareholders' DeficitFrom
                    Inception (September 17, 1998) to December 31, 2006Preferred
                    Stock
                
                
                Common
                    Stock
                
                
                
                
                
                
                
                
                
                
                
                Accumulated
                
                
                TotalAdditional
                
                
                Stock
                    to
                
                
                
                
                
                During
                    the
                
                
                Shareholders'Number
                
                
                
                
                
                Number
                
                
                
                
                
                Paid-in
                
                
                be
                
                
                Treasury
                
                
                Development
                
                
                Equityof
                    Shares
                
                
                Total
                
                
                of
                    Shares
                
                
                Total
                
                
                Capital
                
                
                Issued
                
                
                Stock
                
                
                Stage
                
                
                (Deficit)Founder's
                      shares
                
                
                2,000,000
                
                
                $
                -
                
                
                
                3,000,000
                
                
                $
                300,000
                
                
                $
                (24,488
                )
                
                $
                -
                
                
                $
                -
                
                
                $
                -
                
                
                $
                275,512Shares
                    issued for cash
                
                
                114,825
                
                
                
                241,100
                
                
                
                
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                241,100Net
                      loss for 1999
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                (387,306
                )
                
                
                (387,306
                )Balance,
                    December 31,
                    1999
                
                
                2,114,825
                
                
                
                241,100
                
                
                
                3,000,000
                
                
                
                300,000
                
                
                
                (24,488
                )
                
                
                -
                
                
                
                -
                
                
                
                (387,306
                )
                
                
                129,306Shares
                      issued for cash
                
                
                84,750
                
                
                
                177,975
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                177,975Stock
                    to be issued
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                87,377
                
                
                
                -
                
                
                
                -
                
                
                
                87,377Net
                      loss for 2000
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                (200,874
                )
                
                
                (200,874
                )Balance,
                    December 31,
                    2000
                
                
                2,199,575
                
                
                
                419,075
                
                
                
                3,000,000
                
                
                
                300,000
                
                
                
                (24,488
                )
                
                
                87,377
                
                
                
                -
                
                
                
                (588,180
                )
                
                
                193,784Shares
                      issued for cash
                
                
                26,296
                
                
                
                33,157
                
                
                
                3,700
                
                
                
                370
                
                
                
                18,630
                
                
                
                (18,117
                )
                
                
                -
                
                
                
                -
                
                
                
                34,040Stock
                    to be issued
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                102,507
                
                
                
                -
                
                
                
                -
                
                
                
                102,507Net
                      loss for 2001
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                (175,655
                )
                
                
                (175,655
                )Balance,
                    December 31,
                    2001
                
                
                2,225,871
                
                
                
                452,232
                
                
                
                3,003,700
                
                
                
                300,370
                
                
                
                (5,858
                )
                
                
                171,767
                
                
                
                -
                
                
                
                (763,835
                )
                
                
                154,676Shares
                      issued for cash
                
                
                -
                
                
                
                -
                
                
                
                210,573
                
                
                
                21,057
                
                
                
                308,130
                
                
                
                (171,767
                )
                
                
                -
                
                
                
                -
                
                
                
                157,420Shares
                    issued for services
                
                
                -
                
                
                
                -
                
                
                
                100,000
                
                
                
                10,000
                
                
                
                90,000
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                100,000Net
                      loss for 2002
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                (310,594
                )
                
                
                (310,594
                )Balance,
                    December 31,
                    2002
                
                
                2,225,871
                
                
                
                452,232
                
                
                
                3,314,273
                
                
                
                331,427
                
                
                
                392,272
                
                
                
                -
                
                
                
                -
                
                
                
                (1,074,429
                )
                
                
                101,502Conversion

                      of preferred to common
                
                
                (2,225,871
                )
                
                
                (452,232
                )
                
                
                6,472,022
                
                
                
                647,202
                
                
                
                (194,970
                )
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -Recapitalization
                
                
                -
                
                
                
                -
                
                
                
                3,741,250
                
                
                
                (843,353
                )
                
                
                843,353
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -Shares
                      issued in settlement of interest
                
                
                -
                
                
                
                -
                
                
                
                369,600
                
                
                
                3,696
                
                
                
                1,493,184
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                1,496,880Shares
                    issued in settlement of debt
                
                
                -
                
                
                
                -
                
                
                
                1,186,648
                
                
                
                11,866
                
                
                
                4,794,058
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                4,805,924Shares
                      purchased for cash
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                (13,992
                )
                
                
                -
                
                
                
                (13,992
                )Net
                    loss for 2003
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                (6,715,403
                )
                
                
                (6,715,403
                )Balance,
                      December 31,
                      2003
                
                
                -
                
                
                
                -
                
                
                
                15,083,793
                
                
                
                150,838
                
                
                
                7,327,897
                
                
                
                -
                
                
                
                (13,992
                )
                
                
                (7,789,832
                )
                
                
                (325,089
                )Net
                    loss for 2004
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                (311,793
                )
                
                
                (311,793
                )Balance,
                      December 31,
                      2004
                
                
                -
                
                
                
                -
                
                
                
                15,083,793
                
                
                
                150,838
                
                
                
                7,327,897
                
                
                
                -
                
                
                
                (13,992
                )
                
                
                (8,101,625
                )
                
                
                (636,882
                )Net
                    loss for 2005
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                (285,088
                )
                
                
                (285,088
                )Balance,
                      December 31,
                      2005
                
                
                -
                
                
                
                -
                
                
                
                15,083,793
                
                
                
                150,838
                
                
                
                7,327,897
                
                
                
                -
                
                
                
                (13,992
                )
                
                
                (8,386,713
                )
                
                
                (921,970
                )Shares
                    issued for cash
                
                
                -
                
                
                
                -
                
                
                
                1,500
                
                
                
                15
                
                
                
                1,485
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                1,500Shares
                      issued for services
                
                
                -
                
                
                
                -
                
                
                
                10,000
                
                
                
                100
                
                
                
                900
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                1,000Net
                    loss for 2006
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                -
                
                
                
                (375,339
                )
                
                
                (375,339
                )Balance,
                      December 31,
                      2006
                
                
                -
                
                
                
                -
                
                
                
                15,095,293
                
                
                $
                150,953
                
                
                $
                7,330,282
                
                
                $
                -
                
                
                $
                (13,992
                )
                
                $
                (8,762,052
                )
                
                $
                (1,294,809
                )
  The
          accompanying notes are an integral part of these financial
          statements.
   F-4
  CARIBBEAN
                    AMERICAN HEALTH RESORTS, INC.(A
                    Development Stage Company)Statements
                    of Cash FlowsCumulativefrom
                    inception(September
                    17, 1998)Year
                    ended December 31,
                
                
                to
                    December 31,2006
                
                
                2005
                
                
                2006Cash
                    flows from operating activities:Net
                    loss
                
                $
                (375,339
                )
                
                $
                (285,088
                )
                
                $
                (8,762,052
                )Adjustments
                    to reconcile net loss to net cashused
                    by operating activities:Depreciation
                
                
                430
                
                
                
                -
                
                
                
                430Loss
                    on settlement of obligations
                
                
                -
                
                
                
                -
                
                
                
                4,509,263Issuance
                    of common stock for services
                
                
                1,000
                
                
                
                -
                
                
                
                101,000Issuance
                    of common stock for interest
                
                
                -
                
                
                
                -
                
                
                
                1,496,880Changes
                    in operating assets and liabilities(Increase)
                    decrease in inventory
                
                
                5,453
                
                
                
                (9,307
                )
                
                
                (3,854
                )(Increase)
                    decrease in deposit
                
                
                (205,511
                )
                
                
                (2,458
                )
                
                
                (205,511
                )(Increase)
                    decrease in other current assets
                
                
                4,408
                
                
                
                (250
                )
                
                
                -Increase
                    (decrease) in accounts payable
                
                
                75,961
                
                
                
                (18,286
                )
                
                
                100,955Increase
                    (decrease) in accrued expenses
                
                
                (12,360
                )
                
                
                (1,215
                )
                
                
                12,328Increase
                    (decrease) in accrued interest
                
                
                128,503
                
                
                
                112,529
                
                
                
                366,329Net
                    cash used in operating activities
                
                
                (377,455
                )
                
                
                (204,075
                )
                
                
                (2,384,232
                )Cash
                    flows from investing activities:Purchase
                    of equipment
                
                
                (2,343
                )
                
                
                -
                
                
                
                (2,343
                )Net
                    cash used in investing activities
                
                
                (2,343
                )
                
                
                -
                
                
                
                (2,343
                )Cash
                    flows from financing activities:Proceeds
                    from advances from line of credit
                
                
                -
                
                
                
                (31,246
                )
                
                
                483,117Advances
                    (repayments)  from related party
                
                
                (108,533
                )
                
                
                75,746
                
                
                
                22,149Proceeds
                    from (repayments of) investment payable
                
                
                -
                
                
                
                -
                
                
                
                86,800Issuance
                    of preferred stock
                
                
                -
                
                
                
                -
                
                
                
                452,232Issuance
                    of common stock
                
                
                1,500
                
                
                
                -
                
                
                
                349,685Proceeds
                    from notes payable
                
                
                -
                
                
                
                -
                
                
                
                1,000,000Net
                    cash provided by financing activities
                
                
                (107,033
                )
                
                
                44,500
                
                
                
                2,393,983Net
                    increase (decrease) in cash
                
                
                (486,831
                )
                
                
                (159,575
                )
                
                
                7,408Cash,
                    beginning of period
                
                
                494,239
                
                
                
                653,814
                
                
                
                -Cash,
                    end of period
                
                $
                7,408
                
                
                $
                494,239
                
                
                $
                7,408Supplemental
                    cash flow informationCash
                    paid for interest
                
                $
                4,469
                
                
                $
                713
                
                
                $
                372,114Cash
                    paid for income taxes
                
                $
                -
                
                
                $
                800
                
                
                $
                5,600Non-cash
                    investing and financing activitiesCommon
                    stock issued for debt
                
                $
                -
                
                
                $
                -
                
                
                $
                296,661
  The
        accompanying notes are an integral part of these financial
        statements.
   F-5
   CARIBBEAN
          AMERICAN HEALTH RESORTS,
          INC.
 (A
          Development Stage
          Company)
 Notes
          to Consolidated Financial
          Statements
 December
          31,
          2006
   1.           Organization
          and summary of significant accounting policies
  Organization
          and line of
          business
  Caribbean
            American Health Resorts, Inc., formerly Vital Health Technologies, Inc.,
            (the
“Public Company” or the “Company”) was incorporated on April 11,
            1960.  On March 10, 2003, the Public Company consummated an Agreement
            and Plan of Reorganization to acquire all of the outstanding capital
            stock of
            Caribbean American Health Resorts, Inc. (“CAHR”) a closely held private company,
            in an exchange for 9,786,295 shares of the Public Company’s common stock (“CAHR
            transaction”).  Prior to the CAHR transaction, the Public Company sold
            off its remaining assets and operations and had 3,741,250 shares of common
            stock
            issued and outstanding.  Following the transaction, the Public Company
            changed its name from Vital Health Technologies, Inc. to Caribbean American
            Health Resorts, Inc. and had 13,527,545 shares of common stock issued
            and
            outstanding.
 
 The
          accounting treatment of the CAHR transaction was determined by the
          following:
 
 1.
                The
                    Public Company was a non-operating public company (having no
                    operations or
                    assets);
 2.
                The
                    shareholders of CAHR became the controlling shareholders of the
                    combined
                    company; and
 3.
                The
                    management and operations of the combine company continue to
                    be those of
                    CAHR.
 
 For
            accounting purposes, the CAHR transaction is considered to be a capital
            transaction in substance, rather than a business combination.  The
            result of the CAHR transaction is treated, in the accompanying financial
            statements as equivalent to the issuance of shares by a private company
            (CAHR)
            for the non-monetary assets of a non-operational public company (Public
            Company), accompanied by a recapitalization.  The accounting for the
            CAHR transaction is similar to that resulting from a reverse
            acquisition.  Accordingly, the historical financial information of the
            accompanying financial statements is that of CAHR.  All shares
            included in the Statement of Stockholder’s Equity have been presented as if the
            acquisition had occurred at the date of inception, September 17, 1998,
            of
            CAHR.
 
 The
          shares of the Public Company outstanding prior to the merger (3,741,250)
          have
          been shown as a recapitalization of CAHR as of March 10, 2003.
 
 Caribbean
          American Health Resorts, Inc. (a development stage company) plans to develop
          world class health resorts in the Caribbean Island of Barbados.  The
          health and longevity facilities will provide five star luxury accommodations,
          reconstructive and elective surgery.  Programs will include detox,
          rehab, spa and weight reduction, along with holistic health and longevity
          and a
          full range of traditional spa services.  Caribbean American Healths
          Resorts will also distribute a variety of herbal-based vitamins and dietary
          supplements.
   F-6
 CARIBBEAN
              AMERICAN HEALTH RESORTS,
              INC.
 (A
              Development Stage
              Company)
 Notes
              to Consolidated Financial
              Statements
 December
              31,
              2006
 1.         Organization
          and summary of significant accounting policies
          (continued)
 
 Development
          Stage
          Company
 The
          Company is a development stage company as defined in Statement of Financial
          Accounting Standards ("SFAS") No. 7, "Accounting and Reporting by Development
          Stage Enterprises." The Company is devoting substantially all of its present
          efforts to establish a new business, and its planned principal operations
          have
          not yet commenced.  The Company has not generated any material
          revenues throughout its history. The Company's ability to continue in business
          is dependent upon obtaining sufficient financing or attaining future profitable
          operations.
 
 Cash
          and
          equivalents
  The
          Company considers all liquid investments with a maturity of three months
          or less
          from the date of purchase that are readily convertible into cash to be
          cash
          equivalents.
  Concentration
          of credit
          risk
  Balances
          in bank accounts may, from time to time, exceed federally insured
          limits.  The Company believes that its loss exposure is
          limited.
  Use
          of
          estimates
  The
          preparation of financial statements in conformity with generally accepted
          accounting principles requires management to make estimates and assumptions
          that
          affect certain reported amounts and disclosures.  Accordingly, actual
          results could differ from those estimates.
 
 Net
          loss per
          share
 Basic
          loss per common share is computed by dividing net loss by the weighted-average
          number of shares of common stock outstanding during the
          period.  Diluted loss per share is computed similar to basic loss per
          share except that the denominator is increased to include dilutive options,
          warrants and other potential common stock outstanding during the
          period.
 
 Advertising
  Advertising
          costs are expensed as incurred.  Advertising expenses totaled $329 in
          2006 and $99 in 2005.
 
 Fair
          value of financial
          instruments
 
 SFAS
          No.
          107, “Disclosures About Fair Value of Financial Insturments,” requires the
          Company to disclose, when reasonably attainable, the fair market values
          of its
          assets and liabilities that are deemed to be financial
          instruments.  The carrying amounts and estimated fair values of the
          company’s financial instruments approximate their fair value due to their
          short-term nature.
   F-7
 CARIBBEAN
              AMERICAN HEALTH RESORTS,
              INC.
 (A
              Development Stage
              Company)
 Notes
              to Consolidated Financial
              Statements
 December
              31,
              2006
 1.           Organization
          and summary of significant accounting policies
          (continued)
  Income
          taxes
  The
          Company accounts for income taxes under the liability method required by
          SFAS
          No. 109 which requires the recognition of deferred tax liabilities and
          assets
          for the expected future tax consequences of events that have been included
          in
          the financial statements or tax returns.  Under this method, deferred
          income taxes are recognized for the tax consequences in future years of
          differences between the tax bases of assets and liabilities and their financial
          reporting amounts at each period end based on enacted tax laws and statutory
          tax
          rates applicable to the periods in which the differences are expected to
          affect
          taxable income. Valuation allowances are established, when necessary, to
          reduce
          deferred tax assets to the amount expected to be realized. The provision
          for
          income taxes represents the tax payable for the period and the change during
          the
          period in deferred tax assets and liabilities.
 
 Recent
          accounting
          pronouncements
  In
          February 2007, the FASB issued SFAS No. 159, The Fair Value Option
          for Financial
          Assets and Financial Liabilities.SFAS No. 159 provides companies with an
          option to report many financial instruments and certain other items at
          fair
          value that are not currently required to be measured at fair value. The
          objective of SFAS No. 159 is to reduce both complexity in accounting for
          financial instruments and the volatility in earnings caused by measuring
          related
          assets and liabilities differently. The FASB believes that SFAS No. 159
          helps to
          mitigate accounting-induced volatility by enabling companies to report
          related
          assets and liabilities at fair value, which would likely reduce the need
          for
          companies to comply with detailed rules for hedge accounting. SFAS No.
          159 also
          establishes presentation and disclosure requirements designed to facilitate
          comparisons between companies that choose different measurement attributes
          for
          similar types of assets and liabilities, and would require entities to
          display
          the fair value of those assets and liabilities for which the company has
          chosen
          to use fair value on the face of the balance sheet. The new statement does
          not
          eliminate disclosure requirements included in other accounting standards,
          including requirements for disclosures about fair value measurements included
          in
          SFAS No. 157, Fair Value
          Measurements. This statement is effective as of the beginning of an
          entity’s first fiscal year beginning after November 15, 2007. The Company is in
          the process of evaluating the impact, if any, that the adoption of SFAS
          No. 159
          will have on the Company’s financial statements.
 
 
 
 F-8
 CARIBBEAN
              AMERICAN HEALTH RESORTS,
              INC.
 (A
              Development Stage
              Company)
 Notes
              to Consolidated Financial
              Statements
 December
              31,
              2006
 
 1.           Organization
          and summary of significant accounting policies
          (continued)
 
 Recent
          accounting
          pronouncements (continued)
 
 In
          September 2006, the FASB issued Statement of Financial Accounting Standards
          No.
          157 (“SFAS 157”), Fair Value
          Measurements, which defines fair value, establishes guidelines for
          measuring fair value and expands disclosures regarding fair value
          measurements.  SFAS 157 does not require any new fair value
          measurements but rather eliminates inconsistencies in guidance found in
          various
          prior accounting pronouncements.  SFAS 157 is effective for fiscal
          years beginning after November 15, 2007 with earlier adoption
          permitted.  We are currently evaluating the impact of SFAS 157, but do
          not expect the adoption of SFAS 157 to have a material impact on our financial
          position, results of operations or cash flows.
 
 In
          September 2006, the SEC issued Staff Accounting Bulletin (“SAB”) No. 108, Considering the Effects
          of Prior
          Year Misstatements when Quantifying Misstatements in Current Year Financial
          Statements. SAB No. 108 addresses quantifying the financial statement
          effects of misstatements or, more specifically, how the effects of prior
          year
          uncorrected errors must be considered in quantifying misstatements in the
          current year financial statements. SAB No. 108 does not change the SEC
          staff’s
          previous positions in SAB No. 99, Materiality regarding
          qualitative considerations in assessing the materiality of misstatements.
          SAB
          No. 108 is effective for fiscal years ending after November 15, 2006. The
          adoption of SAB No. 108 did not have a material impact on the Company’s
          financial statements.
 
 In
          July
          2006, the FASB issued Financial Interpretation No. 48, Accounting for Uncertainty
          in Income
          Taxes – an interpretation of FASB Statement No. 109 (“FIN 48”), which is
          a change in accounting for income taxes.  FIN 48 specifies how tax
          benefits for uncertain tax positions are to be recognized, measured, and
          derecognized in financial statements; requires certain disclosures of uncertain
          tax matters; specifies how reserves for uncertain tax positions should
          be
          classified on the balance sheet; and provides transition and interim period
          guidance,  among other provisions.  FIN 48 is effective for
          fiscal years beginning after December 15, 2006.  We do not expect the
          adoption of FIN 48 to have a material impact on our financial position,
          results
          of operations or cash flows.
 
 In
          July
          2006, the Emerging Issues Task Force promulgated Issue No. 06-3 (“Issue”), How Taxes Collected
          from Customers
          and Remitted to Governmental Authorities Should be Presented in the Income
          Statement (i.e., Gross Versus Net Presentation). The Task Force concluded
          that entities should present these taxes in the income statement on either
          a
          gross or a net basis based upon their accounting policy. However, this
          Issue
          states that if such taxes are significant, and are presented on a gross
          basis,
          the amounts of those taxes should be disclosed. This Issue should be applied
          to
          financial reports for interim and annual reporting periods beginning after
          December 15, 2006. We do not expect the adoption of this Issue to have
          a
          material impact on our financial position, results or operations or cash
          flows.
   F-9
 CARIBBEAN
              AMERICAN HEALTH RESORTS,
              INC.
 (A
              Development Stage
              Company)
 Notes
              to Consolidated Financial
              Statements
 December
              31,
              2006
 1.           Organization
          and summary of significant accounting policies
          (continued)
 
 Recent
          accounting
          pronouncements (continued)
 
 In
          February 2006, the FASB issued Statement of Financial Accounting Standards
          No.
          155 (“SFAS 155”), Accounting
          for Certain Hybrid Financial Instruments.  SFAS 155 simplifies
          the accounting for certain derivatives embedded in other financial instruments
          by allowing them to be accounted for as a whole if the holder elects to
          account
          for the whole instrument on a fair value basis.  SFAS 155 is effective
          for all financial instruments acquired, issued or subject to a re-measurement
          event occurring in fiscal years beginning after September 15,
          2006.  Earlier adoption is permitted, provided the company has not yet
          issued financial statements, including for interim periods, for that fiscal
          year.  The Company will adopt SFAS 155 in the first quarter of
          2007.  We do not expect the adoption of SFAS 155 to have a material
          impact on our financial position, results of operations or cash
          flows.
 2.         Deposit
 
 During
            2006, the Company put a deposit on a proposed development of a property
            called
            Northpointe in Barbados totaling $203,053, however, the development of
            the
            property did not materialize and the deposit was returned to the Company
            during
            the second quarter of 2007.
  3.          Note
          payable
 
 The
          Company obtained a note payable of $1,000,000 from Sonsai
          Corporation.  The note renews annually on December 31 and bears
          interest at 10%.
 
 4.          Related
          party transactions
 
 The
          Company has received advances from a shareholder totaling
          $22,150.  These advances are due on demand and bear no
          interest.
 
 5.         Shareholders’
          equity (deficit)
 
 Preferred
          stock
          issuances
 In
          1999,
          the Company issued 2,000,000 founder’s shares of its preferred stock to the
          president of the Company for $-0-.
 
 In
          1999,
          the Company issued 2,114,825 shares of its preferred stock for
          $241,100.  Each share is convertible into three shares of common
          stock.
 
 In
          2000,
          the Company issued 84,750 shares of its preferred stock for
          $177,975.  Each share is convertible into two shares of common
          stock.  In addition, an additional $18,117 was received for preferred
          stock, but the stock was not issued until 2001.
 
 In
          2001,
          the Company issued 26,296 shares of its preferred stock for $33,157, which
          includes the $18,117 received in the prior year.  Each share is
          convertible into two shares of common stock.
 
   F-10
 CARIBBEAN
              AMERICAN HEALTH RESORTS,
              INC.
 (A
              Development Stage
              Company)
 Notes
              to Consolidated Financial
              Statements
 December
              31,
              2006
 
 5.         Shareholders’
          equity (deficit)
 
 Preferred
          stock issuances
          (continued)
 
 Effective
          with the merger of CAHR and Vital Health, all preferred shares were converted
          into common stock.
 
 Common
          stock
          issuances
 In
          1999,
          the Company issued 3,000,000 founder’s shares of its common stock to the
          president o fhte Company for $3,000.
 
 In
          2000,
          the Company received $69,200 for shares, but did not issue these shares
          until
          2001 and 2002.
 
 In
          2001,
          the Company issued 3,700 shares of its common stock for $19,000.  In
          addition, an additional $102,507 was received for common stock, but the
          stock
          was not issued until 2002.
 
 In
          2002,
          the Company issued 210,573 shares of its common stock for $329,187, which
          includes the $69,260 and $102,507 received in 2000 and 2001,
          respectively.  In addition, the Company issued 100,000 shares of its
          common stock for services valued at $100,000.
 
 During
          year ended December 31, 2003, the Company purchased 2,965 shares of treasury
          stock totaling $13,992 through an open market using the cost
          method.
 
 Effective
          with the merger of CAHR and Vital Health, preferred shares were converted
          into
          6,472,020 shares of common stock and an additional 3,741,250 shares were
          issued.
 
 In
          December 2003, 369,600 shares of the Company’s common stock valued at $1,496,880
          were issued in settlement of interest expense totaling
          $1,719,000.  The gain on this transaction is netted with the losses on
          other transactions in the caption “Loss on Settlement of Obligations” in the
          accompanying statement of operations.
 
 In
          December 2003, 1,186,648 shares of the Company’s common stock valued at
          $4,805,924 were issued in settlement of debt totaling $296,661.  The
          loss on this transaction is netted with the gains on other transactions
          in the
          caption “Loss on Settlement of Obligations” in the accompanying statement of
          operations.
 
 In
          2006,
          the Company issued 10,000 shares of the Company’s common stock for $1,000 in
          services rendered and 1,500 shares of the Company’s common stock for $1,500 in
          cash.
 
 
 F-11
  CARIBBEAN
            AMERICAN HEALTH RESORTS,
            INC.
 (A
            Development Stage
            Company)
 Notes
            to Consolidated Financial
            Statements
 December
            31,
            2006
  
 
 6.       Commitments
          and contingencies
 
 Rent
          expense
  In
            May
            1999, the Company entered into a month-to-month term lease and maintains
            its
            operations in Beverly Hills, CA. Rent expense charged to operations totaled
            $37,230 in 2006 and $27,591 in 2005.
  7.        Subsequent
            event
 
 During
            the second quarter of 2007, the Company issued 1,000 shares of common
            stock for
            $140 in cash.
 
 On
            November 30, 2007 Caribbean American Health Resorts, Inc (“CAHR”) entered into
            an MSO Purchase Agreement (the “Agreement”) with Dr. Edward Rubin (“Seller”) to
            purchase HPHPRE, LLC, wholly owned by the Seller. Consideration to be
            paid to
            Dr. Rubin at the closing of the transaction will consist of a $3,000,000
            promissory note and 5,000,000 shares of CAHR’s Common Stock.
    F-12